Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
Clinical trial NCT03860571 · COMPLETED
Trial details
- NCT number
- NCT03860571
- Sponsor
- NImmune Biopharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-06
- Primary completion
- 2018-09-24
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.